Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma

This page shows the latest Purdue Pharma news and features for those working in and with pharma, biotech and healthcare.

FDA awards another non-opioid pain drug breakthrough status

FDA awards another non-opioid pain drug breakthrough status

Meanwhile one company, Purdue Pharma, has become increasingly identified for fuelling the epidemic with its opioid products, especially OxyContin, a timed-release formulation of opioid pain medication oxycodone. ... An in-depth investigation published

Latest news

More from news
Approximately 2 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    825. Exicure (US). Purdue Pharma (US). Research collaboration &options. Spherical Nucleic Acid (SNA) technology for discovery and development of psoriasis treatment; option to AST-005. ... and Bicycle Therapeutics at $1bn, and the Purdue Pharma-Exicure

  • Pharma deals in September 2015 Pharma deals in September 2015

    Let's deal with the pain first …. After last month's deal with Eisai for lemborexant, a phase III insomnia treatment, Purdue Pharma is refocusing on its pain portfolio by ... Collaboration - public private partnership. 220. VM Pharma. Purdue Pharma.

  • Pharma deals during December 2012 Pharma deals during December 2012

    Pharma deals during December 2012. Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month. ... What perhaps is a mystery is why Titan made this deal with a newly formed marketing company rather than Purdue Pharma, a

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Purdue Pharma appoints Dr Craig Landau as its CEO Purdue Pharma appoints Dr Craig Landau as its CEO

    Purdue Pharma appoints Dr Craig Landau as its CEO. He also takes up president role. ... He succeeds Mark Timey who leaves Purdue Pharma to “pursue other career opportunities”.

  • McCann Health expands consulting team McCann Health expands consulting team

    various sales and marketing positions at Johnson &Johnson, Purdue Pharma and Bristol-Myers Squibb.

  • Purdue Pharma appoints Dr Alan Dunton Purdue Pharma appoints Dr Alan Dunton

    Purdue Pharma appoints Dr Alan Dunton. He joins the pain specialist as senior VP of research and development. ... Purdue Pharma has appointed Dr Alan Dunton as senior vice president of research and development in a role that also sees him join its

  • Purdue looks to Merck for new CEO Purdue looks to Merck for new CEO

    Purdue looks to Merck for new CEO. Mark Timney will lead pain specialist. ... Purdue Pharma has appointed Merck &Co veteran Mark Timney as CEO, replacing John Stewart who retires.

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics